FDA Approval of Zilretta

Hospitals

DrueOctober 6, 2017
821

Flexion Therapeutics Announces FDA Approval of Zilretta™ for Osteoarthritis (OA) Knee Pain

BURLINGTON, Mass., Oct. 06, 2017 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug…
Read More »